Drug – bio-affecting and body treating compositions – Obesity
Reexamination Certificate
2011-04-05
2011-04-05
Desai, Anand U (Department: 1615)
Drug, bio-affecting and body treating compositions
Obesity
C514S567000
Reexamination Certificate
active
07919533
ABSTRACT:
The present invention relates to a method of administering an effective amount of a diiodothyroacetic acid in order to shift the proportion between lean body mass and adipose tissue in favor of lean body mass in human individuals.
REFERENCES:
patent: 3198702 (1965-08-01), Hellbaum
patent: 4490221 (1984-12-01), Collange et al.
patent: 4672691 (1987-06-01), De Garie et al.
patent: 4673691 (1987-06-01), Bachynsky
patent: 5910569 (1999-06-01), Latham et al.
patent: 6380255 (2002-04-01), Lavin
Pittman et al., “Effect of thyroxine analogs on the peripheral metabolism of thyroxine: the half-life and pattern of elimination.” Endocrinology (1964), 74 (4), 611-6 (CAPLUS abstract).
Benedetti, A. “Influence of some thyroxine derivatives on the glycoactive adrenal secretion.” Folia Endocrinologica (1961), 14, 253-9 (CAPLUS abstract).
Beneditti, A. “Influence of some thyroxine derivatives on the glycoactive adrenal secretion” Folia Endrocrinolgica (1961), 14, 253-9 (CAPLUS abstract).
Pittman, C.S. et al. “Effect of thyroxine analog on the peripheral metabolism of thyoxine: the half life and pattern of elimination” Endocrinology (1964), 74 (4), 611-6.
Rutgers, et al. Indentification of 3,3-diiodothyroacetic acid sulfate: A major metabolite of 3,3,5-triiodothyronine in propylthiourocil treated rats, 1990, Endocrinology, vol. 124. p. 1617-1624.
Benedetti, A. Influence of some thyroxine derivatives on the glycoactive adrenal secretion (abstract).
Pittman, et al. Effects of thyroxine analogs on the periheral metabolism of thyroxine: the half life and pattern of elimination (abstract).
Rutgers et al. Endocrinology.
Pittman et al. Endocrinology.
Rutgers, et al. Identification of 3,3′-diidothyroacetic acid sulfate: A major metabolite of 3,3′5-trithyronine in propylthiouracil treated rats, Endocrinology, vol. 127, No. 4, 1990.
Marja Rutgers, “Identification of 3,3′-Diodothyroacetic acid sulfate:A major metabolite of 3,3′,5-triiodothyronine in Propylthiouracil-treated rats” Endocrinology 1990;p. 1617.
I Várnai, M Farkas: Acta Physiol Hung. Acad. Sci. Hung. 1959; 15: 151-60.
I Várnai, M Farkas, SZ Donhoffer: Acta Physiol Hung. Acad. Sci. Hung. 1959; 16: 197-201.
M Rutgers, FA Heusdens, F Bonthuis and TJ Visser. Endocrinology. Jul. 1989;125(1):433-43.
M Rutgers, FA Heusdens, TJ Visser. Endocrinology. Jul. 1989;125(1):424-32.
O'Connell, M. et al, “Changes in serum concentrations of 3,3′,5′-thriiodothyronine and 3,5,3′-triiodothyronine during prolonged moderate exercise,” J Clin Endocrinol Metab. Aug. 1979, V.49(2), pp. 242-246.
Epstein, Y. et al.,“Serum 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine concentrations during acute heat load,” J Clin Endocrinol Metab. Nov. 1979, V. 49(5), pp. 677-678.
“Sur le metabolisme de la 3:3′:5′-triiodothyronine,” Biochimica et Biophysica Acta. Dec. 1956, V.22 (3), pp. 550-557.
“Inhibition of Thyroxine Action By 3,3′,5′-Triiodothyronine,” Endocrinology, V. 64 (3), pp. 466-468.
“Metabolic effects of thyroid hormone derivatives,” Thriod, Feb. 2008, (2), pp. 239-253.
Pittman et al., “Biological Activity of 3,3′,5′-Triiodo-DL-Thyronine,” Endocrinology, V. 70 (1), pp. 79-83.
Sachs, Marvin L., “Abnormalities of cholesterol metabolism in hypothyroidism and the effects of treatment with thyroid hormones and thyroxin analogues,” Journal of Chronic Diseases, Nov. 1961, V. 14 (5), pp. 515-536.
Abraham Sal
Kramer Ron
Booth Udall, PLC
Desai Anand U
Mercier Melissa S
LandOfFree
Diiodothyroacetic acid and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diiodothyroacetic acid and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diiodothyroacetic acid and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702308